ANI Pharmaceuticals ANIP Total costs & expenses

Total costs & expenses at other companies

ALN

Alnylam PharmaceuticalsALNY

$1.06B+34.1%

Aurinia PharmaceuticalsAUPH

$36.88M-26.1%

Zevra Therapeutics, Inc.ZVRA

$21.05M-13.1%

LQD

Liquidia CorporationLQDA

$86.16M+85.9%

Acadia PharmaceuticalsACAD

$270.12M+16.3%

FAQ

What is ANI Pharmaceuticals's total costs & expenses?

ANI Pharmaceuticals (ANIP) reported total costs & expenses of $225.58M in Q2 2026.

How has ANI Pharmaceuticals's total costs & expenses changed year-over-year?

ANI Pharmaceuticals's total costs & expenses increased by 14.2% year-over-year, from $197.48M to $225.58M.

What is the long-term trend for ANI Pharmaceuticals's total costs & expenses?

Over 4 years (2021 to 2025), ANI Pharmaceuticals's total costs & expenses has grown at a 31.8% compound annual growth rate (CAGR), from $255.93M to $772.27M.

What does total costs & expenses mean?

This represents the aggregate of all operating and non-operating costs incurred by the company to generate revenue, including cost of goods sold, research and development, and administrative overhead. It serves as a comprehensive measure of the company's total cost structure and operational scale. Analyzing this metric relative to revenue growth provides insight into the company's overall operating leverage and cost management discipline.